Ashutosh Sharma, PhD is Vice President and Chief Scientific Officer for Jeiven and is responsible for providing a strategic vision to the development of client projects in the areas of medical devices, pharmaceuticals, combination drug/devices, in-vitro diagnostics, drug delivery, and iontophoretic products. With over 20 years of experience in the Pharmaceutical, Drug Delivery and Medical Device industries Dr. Sharma helps companies by leading technical development efforts, creating product development and manufacturing strategies. Ash performs audits at client sites and their suppliers with focus on CAPAs, data integrity, complaint handling systems, adverse events, non-conformance, filing of MDRs & ADRs and general Quality Systems to address FDA regulations and concerns. Ash also helps companies stay up-to-date with industry regulations though GMP, GLP, and QSR in-house custom trainings.
Prior to Jeiven, Ash was Chief Strategic Officer at Vyteris, Inc. a specialty pharmaceutical company, where his efforts were focused on promoting Vyteris’ Smart Patch technology, and identifying licensing and development opportunities for the technology. He also led the development of Vyteris’ active transdermal drug delivery systems based on the company’s patented platform technology which resulted in approval of first-ever active patch combination drug/device product by the FDA.